AXT-1003 Combination With Enzalutamide in Participants With mCRPC

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The purpose of this study is to evaluate the efficacy, and safety of AXT-1003 combined with Enzalutamide in subjects with advanced prostate cancer.
Epistemonikos ID: ac1c5d16fe939ed3252559ad4719273302a640c4
First added on: Oct 28, 2026